PROSIGNA Trademark

Prosecution Summary

Trademark Summary
The standard character mark PROSIGNA is a service mark covering scientific laboratory testing, reporting, genomic and transcriptomic sequencing, and analysis services for research purposes in the field of breast cancer in International Class 042, and medical testing, reporting, diagnostic, genomic, and transcriptomic services for breast cancer in International Class 044. It is owned by Veracyte, Inc., a Delaware corporation based in South San Francisco, California, and filed on an intent-to-use basis with claimed prior registrations 4585174 and 6931617. The application is currently published for opposition as of March 10, 2026, with the opposition period beginning on that date. No notable issues or legal proceedings are present.

Recent Activity
Fi

Trademark Facts

Goods & Services

Medical testing and reporting services for diagnostic, prognostic and predictive purposes for breast cancer; Medical diagnostic testing services in the field of breast cancer; Genomic and transcriptomic sequencing and analysis services for medical diagnostic and treatment purposes for breast cancer; Scientific testing and reporting services for diagnostic, prognostic, and predictive purposes for breast cancer; Scientific laboratory testing services for breast cancer; Genomic and transcriptomic sequencing and analysis services for medical research purposes for breast cancer

Recent Prosecution Activity

USPTO Refusals on Record

• indefinite_identification

Related

• All trademarks from Veracyte, Inc.
• More marks in Class 042
• Search for similar marks to PROSIGNA
• Run a clearance check
• Free USPTO trademark search